My watch list  


Systematic (IUPAC) name
CAS number 17-7-4
ATC code R06AA04
PubChem 2781
DrugBank APRD00875
Chemical data
Formula C21H26ClNO 
Mol. mass 343.9
Pharmacokinetic data
Bioavailability 39.2%
Metabolism Hepatic
Half life 21.3 Hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.


Legal status


Routes Oral

Clemastine, also known as meclastin, is an antihistamine drug. Unlike loratadine or fexofenadine, clemastine is a sedating antihistamine, however it exhibits fewer side effects than most of the widely used antihistamines. Clemastine is also classified as an antipruritic (i.e. it stops itching).



Clemastine is an antihistamine with anticholinergic and sedative effects. Antihistamines competitively bind to histamine receptor sites, thus reducing the neurotransmitter's effects. Effects of histamine (which are countered by antihistamines) include:

  • Increased capillary permeability
  • Increased capillary dilatation
  • Edema (i.e. swelling)
  • Pruritus
  • Gastrointestinal/respiratory smooth muscle constriction

Clemastine inhibits both the vasoconstrictor and vasodilator effects of histamine. Depending on the dose, the drug can produce paradoxical effects, including CNS stimulation or depression.

Most antihistamines exhibit some type of anticholinergic activity. Antihistamines act by competitively binding to H1- receptor sites, thus blocking the binding endogenous histamine. Antihistamines do not chemically inactivate or prevent the normal release of histamine.

Clemastine is rapidly absorbed from the gastrointestinal tract and peak plasma concentrations are attained in 2-4 hours.

Mechanism of Action

Clemastine is a selective histamine H1 antagonist. It binds to the histamine H1 receptor, thus blocking the action of endogenous histamine, which leads to temporary relief of the negative symptoms caused by histamine.


Antihistamines are thought to be metabolized in the liver, mostly by mono-/didemethylation and glucuronide conjugation. It is an inhibitor of cytochrome P450 2D6 and may interfere with other drugs metabolized by this isozyme.


Clemastine is indicated for use in treating allergic rhinitis, such as sneezing, rhinorrhea, pruritus and lacrimation.


Clemastine is an OTC drug, and is available as a syrup (0.5 mg per 5mL) and tablet (1mg). It is sold in the United States under the brand name Tavist.

In Sweden it is, unlike the newer non-sedative antihistamines used for allergy, prescription only and sold under the brand name of Tavegyl.


Overdosage symptoms are paradoxical, ranging from CNS depression to stimulation. Stimulation is most common in children, and is usually followed by excitement, hallucinations, ataxia, incoordination, muscle twitching, athetosis, hyperthermia, cyanosis convulsions, tremors, and hyperreflexia. This may be followed by postictal depression and cardiovascular/respiratory arrest. Other common overdose symptoms include dry mouth, fixed dilated pupils, flushing of the face, and pyrexia. In adults, overdose usually leads to CNS depression, ranging from drowsiness to coma.

The oral LD50 of clemastine in the rat and mouse is 3550 mg/kg and 730 mg/kg, respectively.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Clemastine". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE